We subsequently formulated a more unique probe, [18F]CFA, which was Utilized in The existing analyze To guage dCK activity in tumors when treated with a little molecule dCK inhibitor. This probe can also be remaining studied inside of a scientific trial at our establishment To judge alterations in dCK action next cancer immunotherapy eighteen. PET